CSIMarket
 


Illumina Inc   (ILMN)
Other Ticker:  
 

Cumulative Illumina Inc 's Total Debt to Equity for Trailing Twelve Months Period

ILMN's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

ILMN Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Oct 01 2023)
III. Quarter
(Jul 02 2023)
II. Quarter
(Apr 02 2023)
I. Quarter
(Jan 01 2023)
IV. Quarter
Y / Y Equity Growth -12.94 % -12.38 % -37.24 % -38.57 % -38.56 %
Y / Y Total Debt Growth -25.06 % 49.8 % 125.15 % 28.51 % 17.23 %
Total Debt to Equity for Trailing Twelve Months Period 0.3 0.31 0.28 0.2 0.16
Total Ranking # 745 # 1127 # 1114 # 926 # 976
Seq. Equity Growth -2.59 % -10.02 % -2.06 % 1.42 % -1.96 %
Seq. Total Debt Growth 0 % -33.47 % 0.09 % 12.53 % 99.9 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to repayements of liabilities of 0% Illumina Inc decreased Total Debt to Equity for Trailing Twelve Months Period in the IV. Quarter to 0.3, above Illumina Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Laboratory Analytical Instruments industry 2 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Illumina Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
ILMN Charts and Quotes
Total Debt to Equity ILMN in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 3
Sector # 104
S&P 500 # 677


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.48 0.23 0
(Dec 30 2018)   (Jan 01 2017)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Laboratory Analytical Instruments Industry Total Debt to Equity for Trailing Twelve Months Period
Perkinelmer Inc  0.57 
Harvard Bioscience Inc  0.57 
Revvity Inc   0.50 
Agilent Technologies inc   0.49 
Codex Dna Inc   0.47 
Eyepoint Pharmaceuticals Inc   0.32 
Phenomex Inc   0.30 
Illumina Inc   0.29 
Lifeloc Technologies Inc   0.20 
Bio rad Laboratories Inc   0.13 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com